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Abstract
Background: Health risk appraisal tools may be useful for identifying individuals who would benefit from lifestyle
changes and increased surveillance. We evaluated the validity of the Your Disease Risk tool (YDR) for estimating
relative risk of coronary heart disease (CHD) among middle-aged women.
Methods: We included 55,802 women in the Nurses’ Health Study who completed a mailed questionnaire about
risk factors in 1994 and had no history of heart disease at that time. Participants were followed through 2004 for
the occurrence of CHD. We estimated each woman’s 10-year relative risk of CHD using YDR, and we compared the
estimated YDR relative risk category (ranging from “very much below average” to “very much above average”) to
the observed relative risk for each category using logistic regression. We also examined the discriminatory accuracy
of YDR using concordance statistics (c-statistics).
Results: There were 1165 CHD events during the 10-year follow-up period. Compared to the “about
average” category, the observed age-adjusted relative risk was 0.43 (95 % confidence interval: 0.33, 0.56)
for the “very much below average” category and 2.48 (95 % confidence interval: 1.68, 3.67) for the “very
much above average” category. The age-adjusted c-statistic for the model including the YDR relative risk
category was 0.71 (95 % confidence interval: 0.69, 0.72). The model performed better in younger than
older women.
Conclusion: The YDR tool appears to have moderate validity for estimating 10-year relative risk of CHD in this
population of middle-aged women. Further research should aim to improve the tool’s performance and to examine its
validity in other populations.
Keywords: Coronary heart disease, Women, Risk assessment
Background
Coronary heart disease (CHD) is the leading cause of
death in the United States, and rates continue to rise
globally [1]. Many modifiable risk factors contribute
to CHD incidence [2], and recent studies indicate
that lifestyle factors may be the cause of the majority
of CHD cases. The identification of individuals at
high risk, who are most likely to benefit from life-
style changes and increased surveillance, is import-
ant to decreasing morbidity and mortality from
CHD.
Health risk appraisal tools may be useful for
identifying individuals at increased risk and determin-
ing appropriate target populations for interventions
[1–3]. Several risk prediction tools for CHD and
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cardiovascular disease (CVD) have been developed,
such as the Framingham Risk Score and the PRE-
CARD and PROCAM Risk Scores [4–13]. These
tools, however, focus primarily on traditional clinical
risk factors for CHD, utilize information that is not
easily accessible to patients, and do not incorporate
information on diet or physical activity, which are im-
portant risk factors for CHD [5–13].
Your Disease Risk (YDR) is a publicly-available,
web-based tool (www.yourdiseaserisk.wustl.edu) that
was designed to estimate risk of CHD and other
chronic diseases [5]. Based on self-reported informa-
tion on lifestyle and clinical risk factors, YDR esti-
mates an individual’s relative risk of developing CHD
over the next 10 years, compared to an average per-
son of the same age and sex [5, 14]. Although the
YDR risk assessment tool for CHD has been available
on the Internet since 2004, it has not been formally
evaluated. Given that this tool may be used by a large
number of patients and clinicians for assessing and
communicating about CHD risk, we feel that it is
critical to examine its validity and to provide this in-
formation to the public. Therefore, the purpose of
this study was to examine the validity of YDR for
predicting relative risk of CHD among middle-aged
women, using prospectively-collected data from the
Nurses’ Health Study (NHS).
Methods
Study design and population
The NHS is a prospective cohort study that began in
1976, when 121,700 U.S. female registered nurses be-
tween ages 30 and 55 completed a mailed question-
naire about their lifestyle factors, health behaviors,
and medical histories. Follow-up questionnaires have
been sent to participants every 2 years since enroll-
ment to update this information. Dietary factors
were first assessed in 1980 and are updated every
4 years using a food frequency questionnaire [15].
The Institutional Review Board at Brigham and
Women’s Hospital approved this study and consid-
ered completion of the questionnaires to be in-
formed consent.
In this analysis, we included women who were alive
in 1994 and completed the 1994 questionnaire. We
chose 1994 through 2004 as the follow-up period for
this analysis due to the availability of risk factor
information as well as the age distribution of NHS
participants; this allowed us to evaluate the perform-
ance of the YDR model in middle-aged and older
women. We excluded women who had a history of
myocardial infarction, coronary artery bypass surgery,
or heart failure before 1994 (n = 37,085). We also ex-
cluded participants who missed 10 or more items on
the 1994 food frequency questionnaire, reported eat-
ing less than 500 or more than 3500 kilocalories a
day, or had missing data on any of the YDR risk fac-
tors (n = 9731). A total of 55,802 women were in-
cluded in the final study population.
Your Disease Risk Tool
The YDR tool for CHD was developed by a panel of
epidemiologists, clinicians, and other experts from
the medical community according to methods used
to achieve consensus and risk classification for can-
cer over an extended period of time [5]. These
methods were first used to develop the Harvard
Cancer Risk Index, and are explained in detail in a
report by Colditz et al [5]. The panel generated a list
of genetic, environmental, nutritional, and lifestyle
risk factors that are known causes of CHD or associ-
ated with CHD. Next, using the International Agency
for Research on Cancer (IARC) classification ap-
proach, they classified the risk factors as “definite”,
“probable”, and “possible” risk factors for CHD and
assigned a magnitude of association for each factor
[5, 16]. Prevalences for the risk factors in the U.S.
population were estimated using many different
sources, including data from the Centers for Disease
Control’s Behavioral Risk Factor Surveillance System
(BRFSS) [17] and the National Health and Nutrition
Examination Survey (NHANES) [18]. Risk factors
assessed in the YDR tool are body mass index (BMI)
(for those <60 years old) and waist circumference
(for those ≥60 years old), smoking history, exposure
to secondhand smoke, dietary factors (collectively
known as PrimeScreen [13], a brief 18-item diet as-
sessment), use of vitamin supplements, physical ac-
tivity, high blood pressure, diabetes, total cholesterol
level, and family history of heart disease.
Each individual’s 10-year relative risk (RR) for develop-
ing CHD, compared to an average person of the same
age and sex, is estimated using the following equation:
RR ¼ RRl1  RRl2 …  RR1n
P1  RRC1ð Þ þ 1−P1ð Þ  1:0½   P2  RRC2ð Þ þ 1−P2ð Þ  1:0½  … Pn  RRCnð Þ þ 1−Pnð Þ  1:0½ 
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In this equation, RRln refers to the individual’s assigned
relative risk (RR) for each risk factor, RRCn refers to the
consensus-based relative risk for that risk factor, and Pn
refers to the estimated U.S. population prevalence for
that risk factor (See Table 1) [19]. In other words, the
YDR equation uses data on each individual’s unique set
of risk factors to estimate their relative risk of develop-
ing CHD over the next 10 years, compared to another
person of the same age and sex in the general popula-
tion. Each individual’s relative risk is estimated based on
the consensus-based relative risk for each of their risk
factors, as well as the prevalence of that risk factor in
the U.S. general population. Based on the estimated
YDR relative risk score calculated from this equation,
each individual is then classified into one of seven rela-
tive risk categories, ranging from “very much below
average risk” (estimated RR ≤ 0.2) to “very much above
average risk” (estimated RR > 5.1) (5). For a sample cal-
culation using the YDR equation, see Additional file 1.
Outcomes
The outcome of interest was incident coronary heart dis-
ease (CHD), defined as fatal or nonfatal myocardial in-
farction (MI), occurring between return of the 1994
questionnaire and the end of follow-up on June 1,
2004. As previously stated, we chose 1994 through
2004 as the follow-up period for this analysis due to
the availability of risk factor information as well as
the age distribution of NHS participants. Nonfatal MI
was confirmed using World Health Organization cri-
teria along with a positive electrocardiogram test or
elevated cardiac enzyme levels [15]. Data on deaths
were collected via reports from next of kin, the postal
service, and the National Death Index. Fatal MI cases
were confirmed by patient medical records, autopsy
reports, or death certificates [15].
Assessment of risk factors
Information on risk factors in the study population was
obtained from participants’ responses on the 1994 ques-
tionnaire or as close to 1994 as possible. Studies have
validated self-reported data in the NHS [20–22]. Pearson
correlations for measured versus self-reported values
were 0.59 for physical activity, 0.94 for height, and 0.97
for weight; Pearson correlations for dietary factors
ranged from 0.25–0.61 for intake of fruits, 0.30–0.47 for
intake of vegetables, 0.58-0.79 for intake of whole grains,
and was 0.41–0.59 for intake of fats (including saturated
fat, trans fat and unsaturated fat) [20–22]. Previous stud-
ies also have demonstrated the validity of the shortened
diet assessment, PrimeScreen [13], which is used in
YDR. We re-coded all of the variables from the NHS
data to be as consistent as possible with the risk factor
definitions and categories that are used in the YDR tool
(see Additional file 2 for details).
The YDR tool was specifically designed to use self-
reported risk factor information at one point in time to
estimate relative risk of developing CHD over the next
10 years. It does this based on self-reported information
at a single point in time and does not update this infor-
mation over time. Therefore, although updated risk fac-
tor information is available for participants in the NHS,
we only used participants’ risk factor information as of
1994 for this analysis, in order to be consistent with how
the YDR tool was intended to be used.
Statistical analysis
We examined the observed prevalences of each risk fac-
tor in the NHS study population in 1994 and compared
them to the estimated U.S. prevalences used in the YDR
relative risk calculation. We then fit a series of logistic
regression models with CHD as the outcome, first in-
cluding each individual risk factor in a separate model
and then including all of the individual risk factors in
the same multivariate model, and compared the ob-
served RRs for each risk factor in the study population
to the consensus-based RRs used in the YDR relative
risk calculation.
To examine the predictive ability of the YDR tool,
we then fit a logistic regression model including indi-
cator variables for the YDR relative risk categories as
predictors of CHD. We assessed the calibration of the
tool by comparing the observed RRs for each relative
risk category in the study population to the estimated
YDR relative risk category. To assess the discrimin-
atory accuracy of the tool, we examined the area
under the curve (AUC, or c-statistic) for the logistic
regression model including indicator variables for the
YDR relative risk categories and calculated 95 % con-
fidence intervals for the c-statistics, overall and within
5-year age groups [23]. To evaluate the performance
of the YDR tool in younger and older women, we
used the Rosner and Glynn approach to compare the
c-statistics of the model in women <60 years old and
in women ≥ 60 years old [24].
We performed all statistical analyses using SAS version
9.3 (SAS Institute, Inc, Cary, NC).
Results
The final study population for this analysis included
55,802 women, 97.9 % white, who were aged 47 to 74 in
1994. Women who were included were slightly younger
than those who were excluded (mean age = 60.5 years
versus 61.2 years). During the 10-year follow-up period,
there were 1165 cases of incident CHD among women
who were included in the study population (2.1 %). The
10-year risk of CHD was slightly higher among women
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Table 1 Comparison of observed prevalences of Your Disease Risk (YDR) risk factors with estimated U.S. population prevalences and
observed relative risks of coronary heart disease with consensus–based relative risks among 55,802 Nurses’ Health Study (NHS)
participants, 1994–2004
Risk factor Observed prevalence
of risk factor in NHS
Estimated U.S.
population
prevalence
Observed unadjusted
RR(95 % CI) in NHS
Observed multivariate
RR(95 % CI) in NHS a
Consensus–
based RR
N (%) %
Overweight/Obesity
BMI < 25 kg/m2 (Age < 60) 12,022 (44.3) 50.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
BMI≥ 25– <29 kg/m2 (Age < 60) 7480 (27.5) 20.0 1.21 (0.88–1.65) 1.02 (0.74–1.40) 2.25
BMI≥ 29 kg/m2 (Age < 60) 7664 (28.2) 30.0 2.10 (1.60–2.75) 1.47 (1.09–1.97) 5.00
Waist ≤ 35in (Age≥ 60) 24,381(85.1) 54.7 1.00 (REF) 1.00 (REF) 1.00 (REF)
Waist > 35in (Age≥ 60) 4255 (14.9) 45.3 1.47 (1.24–1.74) 1.23 (1.03–1.46) 2.25
Smoking status
Current smoker, ≥25 cig/day 1068 (1.9) 5.0 2.12 (1.50–2.98) 2.73 (1.92–3.89) 5.00
Current smoker, 15–24 cig/day 2552 (4.6) 10.0 2.48 (1.99–3.09) 3.15 (2.50–3.97) 2.25
Current smoker, ≤ 14 cig/day 2762 (5.0) 9.0 2.61 (2.12–3.21) 3.13 (2.51–3.89) 1.30
Past smoker, quit <2 years ago 1078 (1.9) 6.0 1.80 (1.25–2.60) 1.84 (1.27–2.67) 1.30
Past smoker, quit 2– < 10 years
ago
5439 (9.8) 6.0 1.44 (1.18–1.76) 1.44 (1.17–1.76) 1.30
Past smoker, quit 10– < 20 years
ago
5934 (10.6) 6.0 1.10 (0.89–1.36) 1.13 (0.91–1.40) 1.00
Past smoker, quit ≥20 years ago 11,673 (20.9) 10.0 1.11 (0.94–1.31) 1.09 (0.92–1.29) 1.00
Never smoked 25,296 (45.3) 48.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Exposure to secondhand smoke
(past and never smokers)b
Almost never or occasionally
exposed
37,614 (67.4) 90.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Regularly exposed 18,188 (32.6) 10.0 1.03 (0.91–1.16) 1.20 (1.04–1.37) 1.30
Multivitamin or B complex
≥5 times/week 23,497 (42.1) 60.0 1.01 (0.89–1.13) 1.02 (0.91–1.15) 0.80
<5 times/week 32,305 (57.9) 40.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Physical activity
≥3 hours/week 11,870 (21.3) 19.0 0.79 (0.68–0.92) 0.85 (0.73–1.00) 0.55
<3 hours/week 43,932 (78.7) 81.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
High blood pressurec
Yes 14,227 (25.5) 27.5 2.05 (1.83–2.31) 1.51 (1.33–1.71) 2.25
No 41,575 (74.5) 72.5 1.00 (REF) 1.00 (REF) 1.00 (REF)
Diabetes or high blood sugar
Yes 2180 (3.9) 8.1 4.41 (3.72–5.22) 3.20 (2.67–3.83) 2.25
No 53,622 (96.1) 91.9 1.00 (REF) 1.00 (REF) 1.00 (REF)
Total cholesterol leveld
≤159 3960(7.1) 14.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
160–199 14,062 (25.2) 35.0 0.83 (0.63–1.09) 0.86 (0.66–1.13) 1.30
200–239 26,693 (47.8) 30.0 1.15 (0.90–1.47) 0.98 (0.76–1.26) 2.25
240–299 9542 (17.1) 15.0 1.48 (1.14–1.93) 1.26 (0.96–1.65) 5.00
≥300 1545 (2.8) 6.0 2.56 (1.83–3.58) 2.00 (1.43–2.82) 7.00
Family history of heart disease
Yes 18,234 (32.7) 46.0 1.43 (1.27–1.60) 1.30 (1.15–1.46) 2.25
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who were excluded (3.3 %), which is not surprising given
that one of main reasons for exclusion was a prior his-
tory of heart disease.
The observed prevalences of the YDR risk factors in
the study population and the estimated U.S. population
prevalences are shown in Table 1. The observed preva-
lences of some risk factors in the study population (e.g.
physical activity, high blood pressure, and alcohol intake)
were similar to the estimated U.S. prevalences, although
others were somewhat different. For example, over 57 %
of NHS study participants reported eating at least 5
servings of fruits and vegetables a day, compared to the
estimated U.S. population prevalence of 26 %. Study par-
ticipants also reported lower intake of foods containing
saturated fat and higher intake of foods containing un-
saturated fat and trans fat, compared to the population
U.S. population estimates.
Table 1 also shows the observed RRs for each of the
YDR risk factors in the study population and the
consensus-based RRs. The observed RRs for some of the
Table 1 Comparison of observed prevalences of Your Disease Risk (YDR) risk factors with estimated U.S. population prevalences and
observed relative risks of coronary heart disease with consensus–based relative risks among 55,802 Nurses’ Health Study (NHS)
participants, 1994–2004 (Continued)
No 37,568 (67.3) 54.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Fish
≥2 servings/week 13,961 (25.0) 35.0 0.91 (0.79–1.05) 0.90 (0.78–1.04) 0.55
<2 servings/week 41,841 (75.0) 65.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Fruits and vegetables
≥5 servings/day 31,966 (57.3) 26.0 1.08 (0.96–1.21) 1.11 (0.98–1.26) 0.55
<5 servings/day 23,836 (42.7) 74.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Foods containing whole grainse
≥3 servings/day 3605 (6.5) 11.0 0.83 (0.64–1.07) 0.79 (0.61–1.03) 0.55
<3 servings/day 52,197 (93.5) 89.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Nuts
≥3 servings/week 13,077 (23.4) 12.0 1.06 (0.93–1.21) 0.99 (0.86–1.13) 0.80
<3 servings/week 42,725 (76.6) 88.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Foods containing saturated fatf
≥2 servings/day 14,079 (25.2) 71.0 1.18 (1.03–1.34) 1.08 (0.95–1.24) 1.30
<2 servings/day 41,723 (74.8) 29.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Foods containing trans fatg
≥5 servings/week 35,222 (63.1) 40.0 1.04 (0.92–1.18) 1.00 (0.89–1.14) 1.30
<5 servings/week 20,580 (36.9) 60.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Foods containing unsaturatedh fat
≥5 servings/week 21,565 (38.7) 15.0 0.91 (0.80–1.02) 0.94 (0.83–1.06) 0.80
<5 servings/week 34,237 (61.4) 85.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
Alcohol
none 47,038 (84.3) 89.0 1.00 (REF) 1.00 (REF) 1.00 (REF)
≥1drink/day 8764 (15.7) 11.0 0.82 (0.69–0.97) 0.79 (0.66–0.94) 0.55
REF reference group, RR relative risk, CI confidence interval, BMI Body Mass Index
aMultivariate RRs are adjusted for all risk factors in table
bObserved prevalences and estimated US population prevalences do not include current smokers
cThose who indicated they were on high blood pressure medication were coded in the “yes” category
dThose who indicated “high cholesterol” without specifying a specific level and those who were on statins were coded in the “200–239” category
eExposed group defined as those who ate 3or more servings a day of oats, cereal, cooked cereal, dark bread, brown rice, other grains, bran, popcorn, oat bran or
wheat germ. YDR whole grain question text, “Do you eat 3 or more servings of whole grains per day (wheat bread, whole grain pasta, brown rice, oatmeal, whole
grain breakfast cereal, bran or popcorn)?
fExposed group defined as those who ate 2 or more servings a day of whole milk, butter, cream cheese, lard, red meat, cottage cheese, and other cheese. YDR
saturated fat question text, “Do you usually eat butter, lard, red meat, cheese, or whole milk 2 or more times per day?”
gExposed group defined as those who ate 5 or more servings per week of margarine, vegetable shortening, fried food, store–bought baked goods (pies, sweet
rolls, cakes, cookies, donuts, or brownies). YDR trans fat question text, “Do you eat stick margarine, vegetable shortening, store–bought baked goods (cookies,
cakes, pies) or deep–fried fast food on most days?”
hExposed group defined as those who ate 5 or more servings per week of olive oil or vegetable oil. YDR unsaturated fat question text, “Do you eat oil–based
salad dressing or use liquid vegetable oil for cooking on most days?”
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risk factors, such as obesity and smoking status, were
weaker than the consensus-based RRs. However, most of
the observed associations were in the expected direction
and were fairly similar in magnitude to the consensus-
based RRs.
The observed relative risks for CHD according to esti-
mated YDR relative risk category are shown in Table 2.
Although the observed RRs for each category were
closer to 1 than the estimated RRs, the observed RRs did
increase monotonically with increasing YDR category.
Participants in the lower YDR relative risk categories
had lower CHD risk compared to participants in the
“average” YDR relative risk category; for example, the
age-adjusted RR for participants in the “very much
below average risk” category was 0.43 (95 % CI: 0.33,
0.56). Participants in the higher YDR relative risk cat-
egories had higher CHD risk compared to participants
in the “average” YDR relative risk category; the age-
adjusted RR for participants in the “very much above
average risk” category was 2.48 (95 % CI: 1.68, 3.67).
When we examined the mean age within each of the
estimated YDR relative risk categories, we found that
participants in the two highest YDR relative risk categor-
ies were slightly younger than participants in the other
categories (data not shown), leading to confounding by
age; this explains why adjusting for age led to changes in
the observed relative risks. The results were similar
when the analyses were stratified by age, although the
observed RRs were slightly closer to the estimated YDR
relative risk categories among participants who were
younger than age 60 in 1994.
Table 3 displays the c-statistics for the logistic regres-
sion model with indicator variables for the YDR relative
risk categories. The unadjusted c-statistic among all par-
ticipants was 0.62 (95 % CI: 0.60–0.63), but this in-
creased with adjustment for age; the age-adjusted c-
statistic among all participants was 0.71 (95 % CI: 0.69,
0.72). When the analyses were stratified by age, the YDR
relative risk category model had better discriminatory
accuracy in younger age groups; the c-statistic was 0.71
(95 % CI: 0.69, 0.74) for those age 55 and younger,
whereas it was 0.59 (95 % CI: 0.58, 0.61) for those over
Table 2 Observed relative risks of coronary heart disease according to estimated Your Disease Risk (YDR) relative risk category
among 55,802 Nurses’ Health Study participants, 1994–2004, overall and stratified by age in 1994
Estimated YDR relative risk category N (%) No. cases (total = 1165) Observed RR (95 % CI)a Age–adjusted RR(95 % CI)b
Very much below average (RR≤ 0.2) 23,140 (41.5) 290 0.42 (0.32–0.55) 0.43 (0.33–0.56)
Much below average (0.2 < RR ≤ 0.5) 14,941 (26.8) 308 0.70 (0.53–0.91) 0.68 (0.52–0.89)
Below average (0.5 < RR≤ 0.9) 7278 (13.0) 173 0.81 (0.61–1.07) 0.78 (0.59–1.04)
About average (0.9 < RR≤ 1.1) 2321 (4.2) 68 1.00 (REF) 1.00 (REF)
Above average (1.1 < RR ≤ 2.1) 4369 (7.8) 166 1.31 (0.98–1.74) 1.32 (0.99–1.76)
Much above average (2.1 < RR≤ 5.1) 2836 (5.1) 115 1.40 (1.03–1.90) 1.55 (1.14–2.11)
Very much above average (RR > 5.1) 917 (1.6) 45 1.71 (1.16–2.51) 2.48 (1.68–3.67)
Age < 60 (N = 27,166)
Very much below average (RR≤ 0.2) 11,390 (41.9) 56 0.39 (0.22–0.71) 0.40 (0.22–0.71)
Much below average (0.2 < RR ≤ 0.5) 6923 (25.5) 62 0.72 (0.40–1.29) 0.71 (0.40–1.28)
Below average (0.5 < RR≤ 0.9) 3271 (12.0) 38 0.94 (0.51–1.73) 0.93 (0.50–1.72)
About average (0.9 < RR≤ 1.1) 1129 (4.2) 14 1.00 (REF) 1.00 (REF)
Above average (1.1 < RR ≤ 2.1) 2156 (7.9) 47 1.78 (0.97–3.24) 1.73 (0.95–3.15)
Much above average (2.1 < RR≤ 5.1) 1586 (5.8) 40 2.06 (1.12–3.81) 2.01 (1.09–3.72)
Very much above average (RR > 5.1) 711 (2.6) 26 3.02 (1.57–5.83) 2.97 (1.54–5.74)
Age ≥60 (N = 28,636)
Very much below average (RR≤ 0.2) 11,750 (41.0) 234 0.43 (0.32–0.58) 0.43 (0.32–0.59)
Much below average (0.2 < RR ≤ 0.5) 8018 (28.0) 246 0.67 (0.49–0.90) 0.67 (0.50–0.91)
Below average (0.5 < RR≤ 0.9) 4007 (14.0) 135 0.74 (0.53–1.01) 0.74 (0.54–1.02)
About average (0.9 < RR≤ 1.1) 1192 (4.2) 54 1.00 (REF) 1.00 (REF)
Above average (1.1 < RR ≤ 2.1) 2213 (7.7) 119 1.20 (0.86–1.67) 1.20 (0.87–1.67)
Much above average (2.1 < RR≤ 5.1) 1250 (4.4) 75 1.35 (0.94–1.93) 1.40 (0.98–2.00)
Very much above average (RR > 5.1) 206 (0.7) 19 2.14 (1.24–3.69) 2.27 (1.32–3.93)
REF reference group, RR relative risk, CI confidence interval
aLogistic regression model includes indicator variables representing YDR relative risk categories
bLogistic regression model includes indicator variables representing YDR relative risk categories, and adjusts for age as a continuous variable
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age 70. The c-statistics for the YDR relative risk category
model among women who were less than age 60 and
among women who were 60 or older were significantly
different from one another (p = 0.001).
Discussion
The purpose of this study was to evaluate the validity of
the Your Disease Risk tool for estimating 10-year relative
risk of CHD among middle-aged women. Since the YDR
parameters were developed by a consensus-based
process, this study represents an independent evaluation
of the tool’s performance. Overall, our results show that
YDR had moderate discriminatory accuracy in this
population, as reflected by the unadjusted c-statistic, al-
though the fit of the model improved substantially with
adjustment for age. The YDR tool also seemed to per-
form better among the younger than the older women
in this population.
Other validation studies of CHD risk prediction tools
have had similar results as our study [6, 8, 9, 11, 12, 25].
For example, c-statistics for the Framingham model for
predicting 5-year risk of CHD in an ethnically diverse
population have ranged from 0.40 to 0.83 [23]. It is im-
portant to note that the Framingham model includes age
and estimates absolute risk, while YDR does not include
age and instead estimates an individual’s relative risk
compared to someone of the same age and sex [5]. The
discriminatory accuracy of the Framingham model was
lower when evaluated in an older population (median
age = 73), with c-statistics of 0.58 for both women and
men [26]. These findings are fairly consistent with our
results, since YDR also showed better discrimination in
the younger than the older age groups. This may be
because age is a more important risk factor for CHD in
older individuals, whereas lifestyle factors may be more
important in younger individuals and their role may
lessen with age [25, 27–29].
In another recent paper that examined the validity of
different cardiovascular risk prediction models in various
populations, the original Framingham risk prediction al-
gorithm for CHD had a c-statistic of 0.68 and the Adult
Treatment Panel III risk prediction tool had a c-statistic
of 0.71 in a multi-ethnic cohort of men and women aged
50–74 years [30]. Again, these values are similar to the
c-statistics that were observed for the YDR tool in our
study population. Viewed as a whole, these results indi-
cate that the YDR tool – which uses only simple, self-
reported risk factor information – has similar discrimin-
atory ability as other CHD risk assessment tools that
utilize more detailed clinical information.
Our study has several important strengths. The study
population was large and was assembled from a well-
established cohort with detailed information on many
lifestyle and clinical risk factors. Our outcome of interest
(CHD) was confirmed by medical records, rather than
including self-reported diagnoses [15]. Unlike most other
validated CHD risk prediction tools, YDR includes modi-
fiable risk factors and only requires information that can
be easily self-reported by patients (such as diet, physical
activity, and general clinical risk factors). We calculated
participants’ YDR relative risk scores as they would be
calculated in a real-world setting; data from one point in
time (1994 or as close to 1994 as possible) was used to
calculate the YDR relative risk score over the next
10 years, and risk factor information was not updated
over time. This is consistent with how the YDR tool was
intended to be use.
Our study also has some limitations. We excluded a
large number of women, which reduced the sample size
and could affect the generalizability of our results. In
addition, our study population included only nurses,
who may be different than women in the general popu-
lation. Although some studies have suggested that higher
levels of education may be associated with healthier
Table 3 Discriminatory accuracy for models with Your Disease Risk (YDR) relative risk category among 55,802 Nurses’ Health Study
participants, 1994–2004, overall and stratified by age in 1994
N No. cases YDR relative risk category model:a
C–statistic (95 % CI): 0.62 (0.60–0.63)
Age–adjusted c–statistic (95 % CI): 0.71 (0.69–0.72)
Age–specific c–statistic (95 % CI):
≤55: 14,918 124 0.71 (0.69–0.74)
56–60: 12,469 160 0.66 (0.65–0.68)
61–65: 11,350 244 0.62 (0.61–0.64)
66–70: 11,222 386 0.62 (0.61–0.64)
>70: 5843 251 0.59 (0.58–0.61)
RR relative risk, C-statistic concordance statistic, CI confidence interval
aYDR relative risk category model contains indicator variables representing the YDR risk categories (Very much below average (RR ≤ 0.2), Much below average (0.2
< RR ≤ 0.5), Below average (0.5 < RR ≤ 0.9), About average (0.9 < RR ≤ 1.1), Above average (1.1 < RR ≤ 2.1), Much above average (2.1 < RR ≤ 5.1), Very much above
average (RR > 5.1))
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lifestyle choices and a more favorable cardiovascular risk
factor profile [31], restriction of our study population to
nurses does not imply that the results are only applicable
to nurses. The YDR tool assigns a consensus-based rela-
tive risk to each risk factor that is included. In general,
studies have shown similar associations between dietary
and lifestyle factors and risk of chronic diseases, includ-
ing CHD and cancer, in the NHS population and in
other groups of women [32, 33]. Furthermore, the 10-
year risk of CHD in our study population was 2.1 %,
which is similar to other cohorts of women. For ex-
ample, in a multi-racial cohort of middle-aged women in
the Atherosclerosis Risk in Communities study, the ob-
served risk of CHD was 1.9 % over 9.2 years of follow-
up [34]. In a cohort of Danish women who were aged
30-63 at the beginning of the study, the 10-year risk of
CHD was approximately 2 % [35]. These results show
that the incidence of CHD in our cohort was fairly com-
parable to other groups of women.
In addition, the observed relative risks for the YDR
categories generally were less strong than the relative
risks estimated by the tool. This indicates that the YDR
tool may not be well-calibrated in this population, espe-
cially in the extreme risk categories; it overestimated the
risk in the lower categories, and underestimated the risk
in the higher categories. In reality, the calibration of the
YDR tool, as well as other risk prediction models, may
depend on the distribution of risk factors in the popula-
tion of interest.
Another limitation is that all of the risk factors were
self-reported via mailed questionnaires, which could po-
tentially lead to misclassification. However, several stud-
ies have shown that self-reported data on weight, height,
waist circumference, physical activity, and dietary factors
are valid in this cohort [20–22]; furthermore, YDR was
designed specifically to utilize only information that can
be easily reported by patients or the general public. Our
findings do show that the observed RRs for some of the
YDR risk factors in our study were different than the
consensus-based RRs and different than in previous ana-
lyses in the NHS population. For example, the observed
RR for CHD was 0.99 comparing intake of ≥ 3 servings/
day of nuts vs. <3 servings/day, while a previous NHS
analysis showed a strong inverse association for intake
of nuts [36]. Similarly, the observed RR for CHD was
1.00 comparing those who consumed foods containing
trans fat ≥5 times/week versus <5 times/week, whereas
trans fat intake has been associated with elevated CHD
risk in other NHS analyses [37]. There are several pos-
sible explanations for these differences. First, many of
the variables are not assessed in the same way on
the YDR tool and on the NHS questionnaires (see
Additional file 2 for a side by side comparison of
YDR and NHS variable categories). In particular, the
questions about intake of certain foods that are used
in the YDR tool are far less detailed than the food
frequency questionnaires that are used to assess nu-
tritional intake in the NHS. As a result, there is
likely to be much more misclassification of dietary
factors based on the YDR tool than in other NHS
analyses, which would lead to attenuation of the ob-
served associations. We also used information on dietary
and other risk factors from only one point in time and did
not update it over the course of the 10-year follow-up
period, whereas other NHS analyses do update risk factor
data over time; we performed the analysis in this manner
to be consistent with how the YDR tool incorporates in-
formation on lifestyle and dietary factors. In addition, the
observed RRs for the YDR risk factors in our study are for
10-year risk of CHD, while the consensus-based RRs refer
to lifetime risk of CHD. Finally, with changing standards
of care in the U.S., the impact of dietary and lifestyle fac-
tors on risk of CHD may have changed since the develop-
ment of the YDR tool.
Conclusion
In summary, the YDR tool appears to have moderate val-
idity for estimating 10-year relative risk of CHD in this
population of middle-aged women and to be comparable
to other CHD risk prediction tools. Further research
should aim to improve the performance of the tool and
to examine its validity in other populations.
Additional files
Additional file 1. “Sample YDR Relative Risk Calculation” shows a
sample Your Disease Risk calculation for a hypothetical study
participant. (PDF 316 kb)
Additional file 2. “Comparison of Your Disease Risk variable
categories with NHS variable categories” is a table comparing Your
Disease Risk variable categories and the Nurses’ Health Study
variable categories side by side. (PDF 188 kb)
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